Terms: = Endocrine gland cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB
505 results:
1. Smoking history is associated with reduced efficacy of neoadjuvant therapy in pancreatic adenocarcinoma.
Akumuo RC; Reddy SP; Westwood C; Devarajan K; Barrak D; Reddy SS; Villano AM
J Gastrointest Surg; 2024 May; 28(5):605-610. PubMed ID: 38704197
[TBL] [Abstract] [Full Text] [Related]
2. Analysis of chemoresistance characteristics and prognostic relevance of postoperative gemcitabine adjuvant chemotherapy in pancreatic cancer.
Ren J; Wu S; Su T; Ding J; Chen F; Li J; Wang Z; Han L; Wu Z
Cancer Med; 2024 May; 13(9):e7229. PubMed ID: 38698688
[TBL] [Abstract] [Full Text] [Related]
3. Targeting androgen biosynthesis in prostate cancer: implications on endocrine physiology.
Kango G; Malek R; Mannuel H; Hussain A
Curr Opin Oncol; 2024 May; 36(3):195-201. PubMed ID: 38573209
[TBL] [Abstract] [Full Text] [Related]
4. Serum Lipidome Profiling Reveals a Distinct Signature of Ovarian cancer in Korean Women.
Sah S; Bifarin OO; Moore SG; Gaul DA; Chung H; Kwon SY; Cho H; Cho CH; Kim JH; Kim J; Fernández FM
Cancer Epidemiol Biomarkers Prev; 2024 May; 33(5):681-693. PubMed ID: 38412029
[TBL] [Abstract] [Full Text] [Related]
5. Sellar Reconstruction With a Bioabsorbable Plate After Endoscopic Transsphenoidal Pituitary Adenoma Resection: Safe and Efficacious.
Thorpe RK; Dougherty MC; Walsh JE; Graham SM; Greenlee JDW
Ann Otol Rhinol Laryngol; 2024 May; 133(5):490-494. PubMed ID: 38372259
[TBL] [Abstract] [Full Text] [Related]
6. Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian cancer With
Lorusso D; Raspagliesi F; Ronzulli D; Valabrega G; Colombo N; Pisano C; Cassani C; Tognon G; Tamberi S; Mangili G; Mammoliti S; De Giorgi U; Greco F; Mosconi AM; Breda E; Artioli G; Andreetta C; Casanova C; Ceccherini R; Frassoldati A; Salutari V; Giolitto S; Scambia G
J Clin Oncol; 2024 May; 42(13):1488-1498. PubMed ID: 38315944
[TBL] [Abstract] [Full Text] [Related]
7. K-Ras(V12) differentially affects the three Akt isoforms in lung and pancreatic carcinoma cells and upregulates E-cadherin and NCAM via Akt3.
Geißert R; Lammert A; Wirth S; Hönig R; Lohfink D; Unger M; Pek D; Schlüter K; Scheftschik T; Smit DJ; Jücker M; Menke A; Giehl K
Cell Commun Signal; 2024 Jan; 22(1):85. PubMed ID: 38291468
[TBL] [Abstract] [Full Text] [Related]
8. An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer.
Zhu K; Ma J; Tian Y; Liu Q; Zhang J
BMC Womens Health; 2024 Jan; 24(1):49. PubMed ID: 38238671
[TBL] [Abstract] [Full Text] [Related]
9. Development of pancreatic diseases during long-term follow-up after acute pancreatitis: a post-hoc analysis of a prospective multicenter cohort.
de Rijk F; Sissingh NJ; Boel TT; Timmerhuis HC; de Jong M; Pauw HS; van Veldhuisen CL; Hallensleben ND; Anten M; Brink MA; Curvers WL; van Duijvendijk P; Hazen WL; Kuiken SD; Poen AC; Quispel R; Römkens T; Spanier B; Tan A; Vleggaar FP; Voorburg A; Witteman B; Ali UA; Issa Y; Bouwense S; Voermans RP; van Wanrooij R; Stommel M; van Hooft JE; de Jonge PJ; van Goor H; Boermeester MA; Besselink MG; Bruno MJ; Verdonk RC; van Santvoort HC;
J Gastroenterol Hepatol; 2024 Apr; 39(4):674-684. PubMed ID: 38191176
[TBL] [Abstract] [Full Text] [Related]
10. A meta-analysis of total thyroidectomy and lobectomy outcomes in papillary thyroid microcarcinoma.
Bi J; Zhang H
Medicine (Baltimore); 2023 Dec; 102(50):e36647. PubMed ID: 38115346
[TBL] [Abstract] [Full Text] [Related]
11. Constructing a nomogram based on the distribution of thyroid nodules and suspicious lateral cervical lymph nodes in fine-needle aspiration biopsies to predict metastasis in papillary thyroid carcinoma.
Liu SQ; Feng JW; Yan ZT; Xing XX; Jiang WY; Jiang Y; Qian F; Xing W
Front Endocrinol (Lausanne); 2023; 14():1242061. PubMed ID: 38089614
[TBL] [Abstract] [Full Text] [Related]
12. Risk factors for postoperative pancreatic fistula following non-traumatic, pancreatic surgery. Retrospective observational study.
Mostafa A; Habeeb TA; Neri V; Elshahidy TM; A Fiad A
Ann Ital Chir; 2023; 94():435-442. PubMed ID: 38051507
[TBL] [Abstract] [Full Text] [Related]
13. Large-scale pancreatic cancer detection via non-contrast CT and deep learning.
Cao K; Xia Y; Yao J; Han X; Lambert L; Zhang T; Tang W; Jin G; Jiang H; Fang X; Nogues I; Li X; Guo W; Wang Y; Fang W; Qiu M; Hou Y; Kovarnik T; Vocka M; Lu Y; Chen Y; Chen X; Liu Z; Zhou J; Xie C; Zhang R; Lu H; Hager GD; Yuille AL; Lu L; Shao C; Shi Y; Zhang Q; Liang T; Zhang L; Lu J
Nat Med; 2023 Dec; 29(12):3033-3043. PubMed ID: 37985692
[TBL] [Abstract] [Full Text] [Related]
14. Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged Nanocells.
Ganju V; Marx G; Pattison S; Amaro-Mugridge NB; Zhao JT; Williams BRG; MacDiarmid JA; Brahmbhatt H
Clin Cancer Res; 2024 Jan; 30(2):304-314. PubMed ID: 37976042
[TBL] [Abstract] [Full Text] [Related]
15. Evaluations of the combined use of blood- and tissue-based protein biomarkers for pancreatic cancer.
Wiewiora M; Jopek J; Świętochowska E; Grynkiewicz M; Piecuch J
Clin Hemorheol Microcirc; 2024; 86(3):383-393. PubMed ID: 37955083
[TBL] [Abstract] [Full Text] [Related]
16. Characterization of the genomic alterations in poorly differentiated thyroid cancer.
Lee Y; Moon S; Seok JY; Lee JH; Nam S; Chung YS
Sci Rep; 2023 Nov; 13(1):19154. PubMed ID: 37932340
[TBL] [Abstract] [Full Text] [Related]
17. Risk-stratified Distant Metastatic Thyroid cancer with Clinicopathological Factors and BRAF/TERT Promoter Mutations.
Cheng X; Zhou Y; Xu S; Yu H; Wu J; Bao J; Zhang L
Exp Clin Endocrinol Diabetes; 2023 Nov; 131(11):577-582. PubMed ID: 37922948
[TBL] [Abstract] [Full Text] [Related]
18. Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic cancer.
Sang W; Zhou Y; Chen H; Yu C; Dai L; Liu Z; Chen L; Fang Y; Ma P; Wu X; Kong H; Liao W; Jiang H; Qian J; Wang D; Liu YH
Cancer Discov; 2024 Feb; 14(2):326-347. PubMed ID: 37824278
[TBL] [Abstract] [Full Text] [Related]
19. Risk factors for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3004).
Kim NK; Kim Y; Kim HS; Park SJ; Hwang DW; Lee SJ; Yoo JG; Chang SJ; Son JH; Kong TW; Kim J; Shim SH; Lee AJ; Suh DH; Lee YY
Cancer Med; 2023 Oct; 12(19):19449-19459. PubMed ID: 37768030
[TBL] [Abstract] [Full Text] [Related]
20. Development and validation of a nomogram for predicting the early death of anaplastic thyroid cancer: a SEER population-based study.
Cui H; Wang R; Zhao X; Wang S; Shi X; Sang J
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16001-16013. PubMed ID: 37689588
[TBL] [Abstract] [Full Text] [Related]
[Next]
